Illumina, Inc. v. Molecular Loop Biosciences, Inc.

IPR2024-01419

The PTAB upheld the patentability of claims 1-9 for Molecular Loop Biosciences against Illumina. The Board rejected all grounds of anticipation and obviousness over prior art like Chee, finding that the required 'collapsing step' necessitates combining both target sequence and differentiator tag information.

Jurisdiction
US PTAB
Case Number
IPR2024-01419
Judge(s)
ANNETTE R. REIMERS, SUSAN L. C. MITCHELL, ZHENYU YANG
Decision Date
30 September 2024

Detailed Summary

In this Final Written Decision, the PTAB denied the petitioner’s arguments that claims 1-9 were unpatentable under 35 U.S.C. §§ 102 or 103. The Board clarified key terms, establishing that 'collapsing step' is distinct from the 'determining step,' and ultimately found that prior art (including Chee) failed to teach the essential combination of target sequence and differentiator tag required for accurate error correction as claimed. The patent owner successfully demonstrated conception and diligence regarding the invention.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Illumina, Inc. vs Molecular Loop Biosciences, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2025-00934

Samsung Electronics Co., Ltd. et al.vsWilus Institute of Standards and Technology Inc.

Samsung has filed an IPR petition challenging U.S. Patent 11,159,210, asserting that all nine claims are obvious over the 802.11ax draft standard and two earlier patent publications. The petition relies on expert testimony and argues that the Board should not exercise discretionary denial.

patentIPR2025-00218

Tesla, Inc.vsIntellectual Ventures II

Tesla, Inc.'s IPR challenge against Intellectual Ventures II LLC regarding cellular network resource allocation claims was denied by the PTAB. The Board found that Tesla failed to meet the burden of showing a reasonable likelihood of prevailing on any challenged claim.

patentIPR2025-01239

Apple Inc.vsTelcom Ventures LLC

Apple Inc. filed a motion to dismiss its IPR petition against Telcom Ventures' U.S. Patent 12,028,793, arguing that the Board has not yet ruled on institution and that proceeding would waste resources. The motion seeks pre‑institution dismissal while other related IPRs remain active in parallel litigation.

patentIPR2025-00758

Mercedes-Benz Group AG et al.vsPhelan Group, LLC

Mercedes-Benz Group AG successfully challenged The Phelan Group's driver authentication patent (9908508) at the PTAB. The Board found a reasonable likelihood of prevailing on multiple grounds, including anticipation and obviousness over prior art references like Murphy and Petrik. This decision significantly strengthens Mercedes-Benz's position in related district court litigation against Phelan Group.

patentIPR2025-01068

Element TV Company, LP et al.vsNokia Technologies Oy

Element TV and Nokia reached a settlement and jointly moved to terminate IPR2025‑01068 before the Board could institute the review. The PTAB granted the motion, ending the proceeding and treating the settlement agreement as confidential.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call